Radiomics for the noninvasive prediction of the BRAF mutation status in patients with melanoma brain metastases.
Meißner AK, Gutsche R, Galldiks N, Kocher M, Jünger ST, Eich ML, Montesinos-Rongen M, Brunn A, Deckert M, Wendl C, Dietmaier W, Goldbrunner R, Ruge MI, Mauch C, Schmidt NO, Proescholdt M, Grau S, Lohmann P.
Meißner AK, et al. Among authors: grau s.
Neuro Oncol. 2022 Aug 1;24(8):1331-1340. doi: 10.1093/neuonc/noab294.
Neuro Oncol. 2022.
PMID: 34935978
Free PMC article.